Tue, Sep 30, 2014, 7:06 AM EDT - U.S. Markets open in 2 hrs 24 mins

Recent

% | $
Quotes you view appear here for quick access.

Seattle Genetics Inc. Message Board

  • losinglunch losinglunch Jul 11, 2013 5:15 PM Flag

    Stanford research on CD47

    Any of you following their work? Is this a possible "cure-all" or "cure-most" like they're saying? Is SGEN or anyone else going after this the same way as Stanford?

    Sentiment: Hold

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • $$$$
      The research being produced by the Irv Weissman lab is showing some outstanding promise in murine models. If this work is also being conducted outside of academia, I don't think the players have as yet shown their hand. SGEN's ADC collaboration pipeline is loaded with wild cards, however, and the "undisclosed ADC's" listed w/ Bayer, Pfizer, Astellas, and GSK all may have CD-47/ TSP-1/ SIRP inhibitor/ activator potential. Stanford's claim to initiate human trials by mid-2014 may tease some commercial research into the spotlight. Best to keep an eye out.
      GLTA

 
SGEN
38.39-2.98(-7.20%)Sep 29 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
The Kroger Co.
NYSEMon, Sep 29, 2014 4:02 PM EDT
Civeo Corporation
NYSEMon, Sep 29, 2014 4:00 PM EDT